PURPOSE: Low-grade inflammation, a common feature in type 2 diabetes (DM2), causes some chronic complications in these patients. The present study was aimed to evaluate the effects of ginger (Zingiber officinale) on pro-inflammatory cytokines (IL-6 and TNF-α) and the acute phase protein hs-CRP in DM2 patients as a randomized double-blind placebo controlled trial. METHODS: A total of 64 DM2 patients randomly were assigned to ginger or placebo groups and received 2 tablets/day of each for 2 months. The concentrations of IL-6, TNF-α and hs-CRP in blood samples were analyzed before and after the intervention. RESULTS:Ginger supplementation significantly reduced the levels of TNF-α (P = 0.006), IL-6 (P = 0.02) and hs-CRP (P = 0.012) in ginger group in comparison to baseline. Moreover, the analysis of covariance showed that the group received ginger supplementation significantly lowered TNF- α (15.3 ± 4.6 vs. 19.6 ± 5.2; P = 0.005) and hs-CRP (2.42 ± 1.7 vs. 2.56 ± 2.18; P = .016) concentrations in comparison to control group. While there were no significant changes in IL-6 (7.9 ± 2.1 vs. 7.8 ± 2.9; P > .05). CONCLUSION: In conclusion, ginger supplementation in oral administration reduced inflammation in type 2 diabetic patients. So it may be a good remedy to diminish the risk of some chronic complications of diabetes.
RCT Entities:
PURPOSE: Low-grade inflammation, a common feature in type 2 diabetes (DM2), causes some chronic complications in these patients. The present study was aimed to evaluate the effects of ginger (Zingiber officinale) on pro-inflammatory cytokines (IL-6 and TNF-α) and the acute phase protein hs-CRP in DM2 patients as a randomized double-blind placebo controlled trial. METHODS: A total of 64 DM2 patients randomly were assigned to ginger or placebo groups and received 2 tablets/day of each for 2 months. The concentrations of IL-6, TNF-α and hs-CRP in blood samples were analyzed before and after the intervention. RESULTS:Ginger supplementation significantly reduced the levels of TNF-α (P = 0.006), IL-6 (P = 0.02) and hs-CRP (P = 0.012) in ginger group in comparison to baseline. Moreover, the analysis of covariance showed that the group received ginger supplementation significantly lowered TNF- α (15.3 ± 4.6 vs. 19.6 ± 5.2; P = 0.005) and hs-CRP (2.42 ± 1.7 vs. 2.56 ± 2.18; P = .016) concentrations in comparison to control group. While there were no significant changes in IL-6 (7.9 ± 2.1 vs. 7.8 ± 2.9; P > .05). CONCLUSION: In conclusion, ginger supplementation in oral administration reduced inflammation in type 2 diabeticpatients. So it may be a good remedy to diminish the risk of some chronic complications of diabetes.
Authors: A Ray; M V Huisman; J T Tamsma; J van Asten; B O Bingen; E A B J Broeders; E S Hoogeveen; F van Hout; V A Kwee; B Laman; F Malgo; M Mohammadi; M Nijenhuis; M Rijkée; M M van Tellingen; M Tromp; Q Tummers; L de Vries Journal: Eur J Intern Med Date: 2008-09-07 Impact factor: 4.487
Authors: Joachim Spranger; Anja Kroke; Matthias Möhlig; Kurt Hoffmann; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer Journal: Diabetes Date: 2003-03 Impact factor: 9.461
Authors: Rongxia Liu; Elke H Heiss; Nadine Sider; Andreas Schinkovitz; Barbara Gröblacher; Dean Guo; Franz Bucar; Rudolf Bauer; Verena M Dirsch; Atanas G Atanasov Journal: Mol Nutr Food Res Date: 2015-03-16 Impact factor: 5.914